×

Methods of treating myelodysplastic syndromes using lenalidomide

  • US 9,925,207 B2
  • Filed: 10/17/2014
  • Issued: 03/27/2018
  • Est. Priority Date: 10/15/2002
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of treating acute myeloid leukemia (AML) associated with a myelodysplastic syndrome, the method comprising administering to a patient having AML a therapeutically effective amount of 5-azacytidine, and a therapeutically effective amount of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione or a pharmaceutically acceptable salt thereof wherein 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione is administered in an amount of about 5 mg to about 25 mg per day.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×